Pre-treatment of CT26 cells with the AhR-specific antagonist (CH223191) for 12 hours partially abolished the anti-cell-proliferative effect of El1405CS (Fig. S1J), indicating that the anti-CRC effect of El1405 was associated with the downstream metabolites of L-tryptophan. Here, AHR is linked to colorectal carcinoma.